申请人:Obitsu Tetsuo
公开号:US09085523B2
公开(公告)日:2015-07-21
The present invention provides a compound of which active |form| is represented by a formula (A). and which can be injected into a joint cavity which is an affected part of disorders and can be accumulated in the joint cavity to exert the pharmacological effect thereof in a sustained manner, for the purpose of ameliorating cartilage disorders without developing any side effect. A compound according to the present invention, which is represented by a formula (I):
(wherein all of symbols are as defined in the description), is a compound that can achieve the above-mentioned purpose. This compound does not exhibit any side effect on the cardiovascular system even when the compound is administered in an effective amount for exhibiting a cartilage regeneration activity, and is therefore extremely useful as a safe and effective preventive and/or therapeutic agent for cartilage disorders. Since a suspension produced using this compound can be injected without requiring the incision of the affected part, it can reduce the burden on patients, and is extremely useful as a medicinal agent.
本发明提供了一种化合物,其活性形式由公式(A)表示,并且可以注射到关节腔中,该关节腔是疾病的受影响部位,并且可以在关节腔中积累,以持续发挥其药理作用,以改善软骨疾病而不产生任何副作用。本发明提供的化合物由公式(I)表示:(其中所有符号在说明中定义),是一种可以实现上述目的的化合物。即使以有效量给予该化合物以展示软骨再生活性,该化合物也不会对心血管系统产生任何副作用,因此非常有用作为软骨疾病的安全有效的预防和/或治疗剂。由于使用该化合物制成的悬浮液可以注射而无需切开受影响部位,因此可以减轻患者的负担,是一种非常有用的药物剂。